160169-48-2 Usage
Uses
1. Used as an intermediate in the synthesis of (-)-Lentiginosine:
Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-(2R,3S)-dihydroxrpropanoate is used as a key intermediate in the chemical synthesis process of (-)-Lentiginosine, a naturally occurring alkaloid with potential biological activities. Its unique structure allows it to serve as a crucial building block in the formation of the target compound.
2. Used in Pharmaceutical Industry:
In the pharmaceutical industry, Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-(2R,3S)-dihydroxrpropanoate is used as an intermediate for the development of new drugs. Its specific molecular structure makes it a valuable component in the synthesis of various pharmaceutical compounds, contributing to the advancement of drug discovery and development.
3. Used in Chemical Research:
Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-(2R,3S)-dihydroxrpropanoate is also utilized in chemical research, particularly in the study of organic synthesis and the development of new synthetic methods. Its unique properties and reactivity make it an interesting subject for researchers to explore and understand its potential applications in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 160169-48-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,1,6 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 160169-48:
(8*1)+(7*6)+(6*0)+(5*1)+(4*6)+(3*9)+(2*4)+(1*8)=122
122 % 10 = 2
So 160169-48-2 is a valid CAS Registry Number.
InChI:InChI=1/C18H25NO6/c1-2-24-17(22)16(21)15(20)14-10-6-7-11-19(14)18(23)25-12-13-8-4-3-5-9-13/h3-5,8-9,14-16,20-21H,2,6-7,10-12H2,1H3/t14-,15-,16+/m1/s1
160169-48-2Relevant academic research and scientific papers
Gurjar,Ghosh, Lakshmi,Syamala,Jayasree
, p. 8871 - 8872 (1994)
Simple routes to (1R,2R,8aR)- and (1S,2S,8aS)-lentiginosine have been described, based on Sharpless asymmetric dihydroxylation, starting from (R)- and (S)-pipecolinic acids.
